Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir
NCT05589688
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Acyclovir
Sponsor
University Hospital, Toulouse